Ubiquitin‐specific protease 22 (USP22) stabilizes SIRT1 and activates the PI3K/Akt/mTOR pathway through enhancing SIRT1‐mediated PTEN deacetylation, thereby promoting melanoma metastasis both in vitro and in vivo. This evidence concerns the gene SIRT1 and melanoma.